Context The waiting time for radioactive iodine therapy (WRAIT) after total thyroidectomy
(TT) in patients with papillary thyroid cancer (PTC) and lymph node metastases (N1) has not …

Objective It remains unclear whether the time interval between total thyroidectomy and
radioactive iodine therapy (RAIT) affects clinical outcomes in papillary thyroid carcinoma …

Background It remains unclear whether the time interval between total thyroidectomy and
radioactive iodine (RAI) therapy influences clinical outcomes in papillary thyroid carcinoma …

Objective: Postthyroidectomy radioiodine (RAI) therapy is indicated for papillary thyroid
carcinoma (PTC) with high-risk features. There is variability in the timing of RAI therapy with …

It remains controversial whether papillary thyroid cancer (PTC) patients with low-to
intermediate-risk disease should receive radioactive iodine (RAI) after total thyroidectomy …

Purpose To assess the effect of adding radioactive iodine (RAI) therapy to total
thyroidectomy (TT) on overall survival (OS) in patients presenting with papillary thyroid …

Context The optimal timing to performing thyroid surgery following a diagnosis of papillary
thyroid cancer (PTC) has yet to be fully defined. Objective We aimed to examine if a delayed …

Objective The utility of radioiodine (RAI) therapy in intermediate‐risk papillary thyroid
carcinoma (PTC) remains a topic of ongoing discussion. This systematic review and meta …

Context Current guidelines recommend a selective use of radioiodine treatment (RAI) for
papillary thyroid cancer (PTC). Objective This work aimed to determine how policy changes …

Context: Papillary thyroid cancer (PTC) is the most common endocrine malignancy. The long-
term prognosis is generally excellent. Due to a paucity of data, debate exists regarding the …